Schwab K O, Söhlemann P, Gerlich M, Broecker M, Petrykowski W, Holzapfel H P, Paschke R, Grüters A, Derwahl M
Institute for Pharmacology and Toxicology, University of Wuerzburg, Germany.
Exp Clin Endocrinol Diabetes. 1996;104 Suppl 4:124-8. doi: 10.1055/s-0029-1211719.
4 patients of two families with congenital persistent hyperthyroidism without detectable autoantibodies are reported. The members of the first family affected by hyperthyroidism, i.e. the mother and her two children, showed a germline mutation, a transition of GCC to GTC in the genomic DNA of the TSH receptor, leading to an exchange of alanine by valine at the position 623. The mother was thyroidectomized at two times because of recurrent nodular goiter. The third child of a healthy second family showed a transition of AGC to AAC leading to an exchange of serine by asparagine at the position 505 of the TSH receptor. The mutation of family 1, as a somatic point mutation leading to autonomous thyroid adenoma, has originally been demonstrated to constitutively activate TSH independent cAMP accumulation. The functional tests of the TSH receptor gen mutation, detected in family 2, are ongoing, but an exchange of serine by arginine at the same position has been shown to lead to constitutively active cAMP accumulation. The cases of congenital hyperthyroidism in the first family lead to a reduction of the birth weight and head circumference and to a neonatal but not fetal tachycardia. Bone age of both children was accelerated by one year. In contrast to that, congenital hyperthyroidism of the second family lead to more marked signs of intrauterine hyperthyroidism. The mother observed marked symptoms of fetal and neonatal hyperthyroidism. The bone age at a chronological age of 6 months was 4-6 years and the neonate showed a mild exophthalmus. We conclude, that congenital hyperthyroidism due to constitutively activating TSH receptor mutations has to be considered, if hyperthyroidism is not transient but persistent, and the parameters of autoimmunity are absent. Constitutively active TSH receptor germline mutations lead to different degrees of congenital hyperthyroidism. In contrast to patients with Graves' disease, more aggressive means of treatment like total thyroidectomy and/or radiation seem to be recommendable in cases with severe hyperthyroidism to control the disease.
报告了两个家族中4例先天性持续性甲状腺功能亢进患者,未检测到自身抗体。第一个家族中受甲状腺功能亢进影响的成员,即母亲和她的两个孩子,在促甲状腺激素(TSH)受体的基因组DNA中显示出种系突变,即GCC向GTC的转换,导致623位的丙氨酸被缬氨酸取代。母亲因复发性结节性甲状腺肿接受了两次甲状腺切除术。健康的第二个家族的第三个孩子显示AGC向AAC的转换,导致TSH受体505位的丝氨酸被天冬酰胺取代。家族1的突变,作为导致自主性甲状腺腺瘤的体细胞点突变,最初已被证明可组成性激活不依赖TSH的环磷酸腺苷(cAMP)积累。在家族2中检测到的TSH受体基因突变的功能测试正在进行中,但已显示相同位置的丝氨酸被精氨酸取代会导致组成性激活的cAMP积累。第一个家族的先天性甲状腺功能亢进病例导致出生体重和头围降低,以及新生儿心动过速,但不是胎儿心动过速。两个孩子的骨龄都提前了一年。与此相反,第二个家族的先天性甲状腺功能亢进导致更明显的宫内甲状腺功能亢进迹象。母亲观察到胎儿和新生儿甲状腺功能亢进的明显症状。6个月实际年龄时的骨龄为4 - 6岁,新生儿表现出轻度突眼。我们得出结论,如果甲状腺功能亢进不是短暂的而是持续的,且不存在自身免疫参数,则必须考虑由组成性激活TSH受体突变引起的先天性甲状腺功能亢进。组成性激活的TSH受体种系突变会导致不同程度的先天性甲状腺功能亢进。与格雷夫斯病患者不同,在严重甲状腺功能亢进的病例中,似乎建议采用更积极的治疗方法,如全甲状腺切除术和/或放射治疗来控制疾病。